Search

Your search keyword '"Budde, Lihua E."' showing total 347 results
Start Over Author "Budde, Lihua E."
347 results on '"Budde, Lihua E."'

1. PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial

Author

Dorff, Tanya B., Blanchard, M. Suzette, Adkins, Lauren N., Luebbert, Laura, Leggett, Neena, Shishido, Stephanie N., Macias, Alan, Del Real, Marissa M., Dhapola, Gaurav, Egelston, Colt, Murad, John P., Rosa, Reginaldo, Paul, Jinny, Chaudhry, Ammar, Martirosyan, Hripsime, Gerdts, Ethan, Wagner, Jamie R., Stiller, Tracey, Tilakawardane, Dileshni, Pal, Sumanta, Martinez, Catalina, Reiter, Robert E., Budde, Lihua E., D’Apuzzo, Massimo, Kuhn, Peter, Pachter, Lior, Forman, Stephen J., and Priceman, Saul J.

Published
2024
Full Text
View/download PDF

6. Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory diffuse large B-cell lymphoma

Author

Bartlett, Nancy L., Assouline, Sarit, Giri, Pratyush, Schuster, Stephen J., Cheah, Chan Y., Matasar, Matthew, Gregory, Gareth P., Yoon, Dok Hyun, Shadman, Mazyar, Fay, Keith, Yoon, Sung-Soo, Panizo, Carlos, Flinn, Ian, Johnston, Anna, Bosch, Francesc, Sehn, Laurie H., Wei, Michael C., Yin, Shen, To, Iris, Li, Chi-Chung, Huang, Huang, Kwan, Antonia, Penuel, Elicia, and Budde, Lihua E.

Published
2023
Full Text
View/download PDF

8. Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study

Author

Budde, Lihua E, Sehn, Laurie H, Matasar, Matthew, Schuster, Stephen J, Assouline, Sarit, Giri, Pratyush, Kuruvilla, John, Canales, Miguel, Dietrich, Sascha, Fay, Keith, Ku, Matthew, Nastoupil, Loretta, Cheah, Chan Yoon, Wei, Michael C, Yin, Shen, Li, Chi-Chung, Huang, Huang, Kwan, Antonia, Penuel, Elicia, and Bartlett, Nancy L

Published
2022
Full Text
View/download PDF

10. Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study

Author

Budde, Lihua E., primary, Assouline, Sarit, additional, Sehn, Laurie H., additional, Schuster, Stephen J., additional, Yoon, Sung-Soo, additional, Yoon, Dok Hyun, additional, Matasar, Matthew J., additional, Bosch, Francesc, additional, Kim, Won Seog, additional, Nastoupil, Loretta J., additional, Flinn, Ian W., additional, Shadman, Mazyar, additional, Diefenbach, Catherine, additional, Cheah, Chan Yoon, additional, Ma, Connie Y., additional, Huang, Huang, additional, Kwan, Antonia, additional, Wei, Michael C., additional, Yin, Shen, additional, and Bartlett, Nancy L., additional

Published
2024
Full Text
View/download PDF

11. Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma

Author

Godfrey, James K., primary, Gao, Lei, additional, Shouse, Geoffrey, additional, Song, Joo Y., additional, Pak, Stacy, additional, Lee, Brian, additional, Chen, Bihong T., additional, Kallam, Avyakta, additional, Baird, John H., additional, Marcucci, Guido, additional, Ghoda, Lucy Y., additional, Vauleon, Stephanie, additional, Danilov, Alexey V, additional, Herrera, Alex F., additional, Kwak, Larry W, additional, and Budde, Lihua E, additional

Published
2024
Full Text
View/download PDF

12. Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study

Author

Kim, Won Seog, Oki, Yasuhiro, Kim, Seok Jin, Yoon, Sang Eun, Ardeshna, Kirit M., Lin, Yi, Ruan, Jia, Porcu, Pierluigi, Brammer, Jonathan E., Jacobsen, Eric D., Yoon, Dok Hyun, Suh, Cheolwon, Suarez, Felipe, Radford, John, Budde, Lihua E., Kim, Jin Seok, Bachy, Emmanuel, Lee, Hun Ju, Bollard, Catherine M., Jaccard, Arnaud, Kang, Hye Jin, Inman, Shannon, Murray, Maryann, Combs, Katherin E., Lee, Daniel Y., Advani, Ranjana, Gunter, Kurt C., Rooney, Cliona M., and Heslop, Helen E.

Published
2021
Full Text
View/download PDF

13. Real‐world experience of axicabtagene ciloleucel, a CD19‐directed CAR T‐cell therapy, in the second‐line treatment of early relapsed or primary refractory large B‐cell lymphoma.

Author

Othman, Tamer, Baird, John H., Pak, Stacy, Mei, Matthew, Herrera, Alex F., Mansour, Joshua, Shouse, Geoffrey, Sahebi, Firoozeh, Spielberger, Ricardo, Cai, Ji‐Lian, Farol, Leonardo, Godfrey, James, Kallam, Avyakta, Phillips, Tycel, Popplewell, Leslie, Siddiqi, Tanya, Forman, Stephen, and Budde, Lihua E.

Subjects
SKIN cancer, T cells, INFORMED consent (Medical law)
Abstract

This article examines the use of axicabtagene ciloleucel (axi-cel), a CAR T-cell therapy, as a second-line treatment for large B-cell lymphoma (LBCL) in a real-world setting. The study analyzes data from patients who received axi-cel at a single center and evaluates various outcomes such as survival rates, response rates, and side effects. The results indicate that axi-cel is effective and well-tolerated, providing valuable insights for its use in clinical practice. However, larger studies with longer follow-up are needed to further validate its efficacy and practicality. [Extracted from the article]

Published
2024
Full Text
View/download PDF

15. Consensus Recommendations on the Management of Toxicity Associated with CD3xCD20 Bispecific Antibody Therapy

Author

Crombie, Jennifer L., primary, Graff, Tara, additional, Falchi, Lorenzo, additional, Karimi, Yasmin H., additional, Bannerji, Rajat, additional, Nastoupil, Loretta J, additional, Thieblemont, Catherine, additional, Ursu, Renata, additional, Bartlett, Nancy L., additional, Nachar, Victoria R, additional, Weiss, Jonathan, additional, Osterson, Jane, additional, Patel, Krish, additional, Brody, Joshua D., additional, Abramson, Jeremy S, additional, Lunning, Matthew A, additional, Shah, Nirav N., additional, Ayed, Ayed, additional, Kamdar, Manali, additional, Parsons, Benjamin M., additional, Caimi, Paolo, additional, Flynn, Ian W., additional, Herrera, Alex F., additional, Sharman, Jeff P., additional, McKenna, Marshall, additional, Armand, Philippe, additional, Kahl, Brad S., additional, Smith, Sonali M, additional, Zelenetz, Andrew D, additional, Budde, Lihua E, additional, Hutchings, Martin, additional, Phillips, Tycel J., additional, and Dickinson, Michael, additional

Published
2024
Full Text
View/download PDF

16. Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial

Author

Budde, Lihua E., primary, Olszewski, Adam J., additional, Assouline, Sarit, additional, Lossos, Izidore S., additional, Diefenbach, Catherine, additional, Kamdar, Manali, additional, Ghosh, Nilanjan, additional, Modi, Dipenkumar, additional, Sabry, Waleed, additional, Naik, Seema, additional, Mehta, Amitkumar, additional, Nakhoda, Shazia K., additional, Smith, Stephen D., additional, Dorritie, Kathleen, additional, Jia, Ting, additional, Pham, Song, additional, Huw, Ling-Yuh, additional, Jing, Jing, additional, Wu, Hao, additional, Ead, Wahib S., additional, To, Iris, additional, Batlevi, Connie Lee, additional, Wei, Michael C., additional, and Chavez, Julio C., additional

Published
2023
Full Text
View/download PDF

17. Mosunetuzumab Safety Profile in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma: Clinical Management Experience from a Pivotal Phase I/II Trial

Author

Matasar, Matthew, primary, Bartlett, Nancy L., additional, Shadman, Mazyar, additional, Budde, Lihua E., additional, Flinn, Ian, additional, Gregory, Gareth P., additional, Kim, Won Seog, additional, Hess, Georg, additional, El-Sharkawi, Dima, additional, Diefenbach, Catherine S., additional, Huang, Huang, additional, To, Iris, additional, Parreira, Joana, additional, Wu, Mei, additional, Kwan, Antonia, additional, and Assouline, Sarit, additional

Published
2023
Full Text
View/download PDF

19. Bendamustine lymphodepletion is a well‐tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B‐cell lymphoma

Author

Ong, Shin Yeu, primary, Pak, Stacy, additional, Mei, Matthew, additional, Wang, Yan, additional, Popplewell, Leslie, additional, Baird, John H., additional, Herrera, Alex F., additional, Shouse, Geoffrey, additional, Nikolaenko, Liana, additional, Zain, Jasmine, additional, Godfrey, James, additional, Htut, Myo, additional, Aribi, Ahmed, additional, Spielberger, Ricardo, additional, Mansour, Joshua, additional, Forman, Stephen J., additional, Palmer, Joycelynne, additional, and Budde, Lihua E., additional

Published
2023
Full Text
View/download PDF

20. Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma

Author

Herrera, Alex F., Rodig, Scott J., Song, Joo Y., Kim, Young, Griffin, Gabriel K., Yang, Dongyun, Nikolaenko, Liana, Mei, Matthew, Bedell, Victoria, Dal Cin, Paola, Pak, Christine, Alyea, Edwin P., Budde, Lihua E., Chen, Robert, Chen, Yi-Bin, Chan, Wing C., Cutler, Corey S., Ho, Vincent T., Koreth, John, Krishnan, Amrita, Murata-Collins, Joyce L., Nikiforow, Sarah, Palmer, Joycelynne, Pihan, German A., Pillai, Raju, Popplewell, Leslie, Rosen, Steven T., Siddiqi, Tanya, Sohani, Aliyah R., Zain, Jasmine, Kwak, Larry W., Weisenburger, Dennis D., Weinstock, David M., Soiffer, Robert J., Antin, Joseph H., Forman, Stephen J., Nademanee, Auayporn P., and Armand, Philippe

Published
2018
Full Text
View/download PDF

21. Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance Rituximab

Author

Mei, Matthew G., Cao, Thai M., Chen, Lu, Song, Joo Y., Siddiqi, Tanya, Cai, Ji-Lian, Farol, Leonardo T., Al Malki, Monzr M., Salhotra, Amandeep, Aldoss, Ibrahim, Palmer, Joycelynne, Herrera, Alex F., Zain, Jasmine, Popplewell, Leslie L., Chen, Robert W., Rosen, Steven T., Forman, Stephen J., Kwak, Larry, Nademanee, Auayporn P., and Budde, Lihua E.

Published
2017
Full Text
View/download PDF

22. Data from The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

Author

Wang, Xiuli, primary, Huynh, Christian, primary, Urak, Ryan, primary, Weng, Lihong, primary, Walter, Miriam, primary, Lim, Laura, primary, Vyas, Vibhuti, primary, Chang, Wen-Chung, primary, Aguilar, Brenda, primary, Brito, Alfonso, primary, Sarkissian, Aniee, primary, Bandara, N. Achini, primary, Yang, Lu, primary, Wang, Jinhui, primary, Wu, Xiwei, primary, Zhang, Jianying, primary, Priceman, Saul J., primary, Qin, Hong, primary, Kwak, Larry W., primary, Budde, Lihua E., primary, Thomas, Sandra H., primary, Clark, Mary C., primary, Popplewell, Leslie, primary, Siddiqi, Tanya, primary, Brown, Christine E., primary, and Forman, Stephen J., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Figures from The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

Author

Wang, Xiuli, primary, Huynh, Christian, primary, Urak, Ryan, primary, Weng, Lihong, primary, Walter, Miriam, primary, Lim, Laura, primary, Vyas, Vibhuti, primary, Chang, Wen-Chung, primary, Aguilar, Brenda, primary, Brito, Alfonso, primary, Sarkissian, Aniee, primary, Bandara, N. Achini, primary, Yang, Lu, primary, Wang, Jinhui, primary, Wu, Xiwei, primary, Zhang, Jianying, primary, Priceman, Saul J., primary, Qin, Hong, primary, Kwak, Larry W., primary, Budde, Lihua E., primary, Thomas, Sandra H., primary, Clark, Mary C., primary, Popplewell, Leslie, primary, Siddiqi, Tanya, primary, Brown, Christine E., primary, and Forman, Stephen J., primary

Published
2023
Full Text
View/download PDF

24. Data from Preserved Activity of CD20-Specific Chimeric Antigen Receptor–Expressing T Cells in the Presence of Rituximab

Author

Rufener, Gregory A., primary, Press, Oliver W., primary, Olsen, Philip, primary, Lee, Sang Yun, primary, Jensen, Michael C., primary, Gopal, Ajay K., primary, Pender, Barbara, primary, Budde, Lihua E., primary, Rossow, Jeffrey K., primary, Green, Damian J., primary, Maloney, David G., primary, Riddell, Stanley R., primary, and Till, Brian G., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Figures 1 through 10 from Preserved Activity of CD20-Specific Chimeric Antigen Receptor–Expressing T Cells in the Presence of Rituximab

Author

Rufener, Gregory A., primary, Press, Oliver W., primary, Olsen, Philip, primary, Lee, Sang Yun, primary, Jensen, Michael C., primary, Gopal, Ajay K., primary, Pender, Barbara, primary, Budde, Lihua E., primary, Rossow, Jeffrey K., primary, Green, Damian J., primary, Maloney, David G., primary, Riddell, Stanley R., primary, and Till, Brian G., primary

Published
2023
Full Text
View/download PDF

26. Data from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

Author

Aldoss, Ibrahim, primary, Khaled, Samer K., primary, Wang, Xiuli, primary, Palmer, Joycelynne, primary, Wang, Yan, primary, Wagner, Jamie R., primary, Clark, Mary C., primary, Simpson, Jennifer, primary, Paul, Jinny, primary, Vyas, Vibhuti, primary, Chien, Sheng-Hsuan, primary, Stein, Anthony, primary, Pullarkat, Vinod, primary, Salhotra, Amandeep, primary, Al Malki, Monzr M., primary, Aribi, Ahmed, primary, Sandhu, Karamjeet, primary, Thomas, Sandra H., primary, Budde, Lihua E., primary, Marcucci, Guido, primary, Brown, Christine E., primary, and Forman, Stephen J., primary

Published
2023
Full Text
View/download PDF

27. Supplemental Figure S5 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

Author

Aldoss, Ibrahim, primary, Khaled, Samer K., primary, Wang, Xiuli, primary, Palmer, Joycelynne, primary, Wang, Yan, primary, Wagner, Jamie R., primary, Clark, Mary C., primary, Simpson, Jennifer, primary, Paul, Jinny, primary, Vyas, Vibhuti, primary, Chien, Sheng-Hsuan, primary, Stein, Anthony, primary, Pullarkat, Vinod, primary, Salhotra, Amandeep, primary, Al Malki, Monzr M., primary, Aribi, Ahmed, primary, Sandhu, Karamjeet, primary, Thomas, Sandra H., primary, Budde, Lihua E., primary, Marcucci, Guido, primary, Brown, Christine E., primary, and Forman, Stephen J., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Table S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

Author

Aldoss, Ibrahim, primary, Khaled, Samer K., primary, Wang, Xiuli, primary, Palmer, Joycelynne, primary, Wang, Yan, primary, Wagner, Jamie R., primary, Clark, Mary C., primary, Simpson, Jennifer, primary, Paul, Jinny, primary, Vyas, Vibhuti, primary, Chien, Sheng-Hsuan, primary, Stein, Anthony, primary, Pullarkat, Vinod, primary, Salhotra, Amandeep, primary, Al Malki, Monzr M., primary, Aribi, Ahmed, primary, Sandhu, Karamjeet, primary, Thomas, Sandra H., primary, Budde, Lihua E., primary, Marcucci, Guido, primary, Brown, Christine E., primary, and Forman, Stephen J., primary

Published
2023
Full Text
View/download PDF

29. CTLA4 blockade induces T cell activation from CTLA4 Promotes Tyk2-STAT3–Dependent B-cell Oncogenicity

Author

Herrmann, Andreas, primary, Lahtz, Christoph, primary, Nagao, Toshikage, primary, Song, Joo Y., primary, Chan, Wing C., primary, Lee, Heehyoung, primary, Yue, Chanyu, primary, Look, Thomas, primary, Mülfarth, Ronja, primary, Li, Wenzhao, primary, Jenkins, Kurt, primary, Williams, John, primary, Budde, Lihua E., primary, Forman, Stephen, primary, Kwak, Larry, primary, Blankenstein, Thomas, primary, and Yu, Hua, primary

Published
2023
Full Text
View/download PDF

30. Supplementary Table 1 from CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells

Author

Wang, Xiuli, primary, Wong, ChingLam W., primary, Urak, Ryan, primary, Mardiros, Armen, primary, Budde, Lihua E., primary, Chang, Wen-Chung, primary, Thomas, Sandra H., primary, Brown, Christine E., primary, La Rosa, Corinna, primary, Diamond, Don J., primary, Jensen, Michael C., primary, Nakamura, Ryotaro, primary, Zaia, John A., primary, and Forman, Stephen J., primary

Published
2023
Full Text
View/download PDF

31. Data from CTLA4 Promotes Tyk2-STAT3–Dependent B-cell Oncogenicity

Author

Herrmann, Andreas, primary, Lahtz, Christoph, primary, Nagao, Toshikage, primary, Song, Joo Y., primary, Chan, Wing C., primary, Lee, Heehyoung, primary, Yue, Chanyu, primary, Look, Thomas, primary, Mülfarth, Ronja, primary, Li, Wenzhao, primary, Jenkins, Kurt, primary, Williams, John, primary, Budde, Lihua E., primary, Forman, Stephen, primary, Kwak, Larry, primary, Blankenstein, Thomas, primary, and Yu, Hua, primary

Published
2023
Full Text
View/download PDF

32. CTLA4 expression by tumor associated B cells from CTLA4 Promotes Tyk2-STAT3–Dependent B-cell Oncogenicity

Author

Herrmann, Andreas, primary, Lahtz, Christoph, primary, Nagao, Toshikage, primary, Song, Joo Y., primary, Chan, Wing C., primary, Lee, Heehyoung, primary, Yue, Chanyu, primary, Look, Thomas, primary, Mülfarth, Ronja, primary, Li, Wenzhao, primary, Jenkins, Kurt, primary, Williams, John, primary, Budde, Lihua E., primary, Forman, Stephen, primary, Kwak, Larry, primary, Blankenstein, Thomas, primary, and Yu, Hua, primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure S4 from CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells

Author

Wang, Xiuli, primary, Wong, ChingLam W., primary, Urak, Ryan, primary, Mardiros, Armen, primary, Budde, Lihua E., primary, Chang, Wen-Chung, primary, Thomas, Sandra H., primary, Brown, Christine E., primary, La Rosa, Corinna, primary, Diamond, Don J., primary, Jensen, Michael C., primary, Nakamura, Ryotaro, primary, Zaia, John A., primary, and Forman, Stephen J., primary

Published
2023
Full Text
View/download PDF

34. CTLA4 is epressed in human B cell lymphoma and multiple myeloma cells from CTLA4 Promotes Tyk2-STAT3–Dependent B-cell Oncogenicity

Author

Herrmann, Andreas, primary, Lahtz, Christoph, primary, Nagao, Toshikage, primary, Song, Joo Y., primary, Chan, Wing C., primary, Lee, Heehyoung, primary, Yue, Chanyu, primary, Look, Thomas, primary, Mülfarth, Ronja, primary, Li, Wenzhao, primary, Jenkins, Kurt, primary, Williams, John, primary, Budde, Lihua E., primary, Forman, Stephen, primary, Kwak, Larry, primary, Blankenstein, Thomas, primary, and Yu, Hua, primary

Published
2023
Full Text
View/download PDF

35. Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma

Author

Ladbury, Colton, primary, Dandapani, Savita, additional, Hao, Claire, additional, Fabros, Mildred, additional, Amini, Arya, additional, Sampath, Sagus, additional, Glaser, Scott, additional, Sokolov, Karen, additional, Yeh, Jekwon, additional, Baird, John H., additional, Kambhampati, Swetha, additional, Herrera, Alex, additional, Mei, Matthew, additional, Nikolaenko, Liana, additional, Shouse, Geoffrey, additional, and Budde, Lihua E., additional

Published
2023
Full Text
View/download PDF

36. Phase 1 studies of central memory–derived CD19 CAR T–cell therapy following autologous HSCT in patients with B-cell NHL

Author

Wang, Xiuli, Popplewell, Leslie L., Wagner, Jamie R., Naranjo, Araceli, Blanchard, M.Suzette, Mott, Michelle R., Norris, Adam P., Wong, ChingLam W., Urak, Ryan Z., Chang, Wen-Chung, Khaled, Samer K., Siddiqi, Tanya, Budde, Lihua E., Xu, Jingying, Chang, Brenda, Gidwaney, Nikita, Thomas, Sandra H., Cooper, Laurence J.N., Riddell, Stanley R., Brown, Christine E., Jensen, Michael C., and Forman, Stephen J.

Published
2016
Full Text
View/download PDF

37. A Phase I California Cancer Consortium Study of Blinatumomab/Lenalidomide in Relapsed/Refractory Non-Hodgkin Lymphoma: Updated Results and Immune Correlative Analyses

Author

Othman, Tamer, primary, Ruel, Christopher, additional, Frankel, Paul, additional, Merleev, Alexander A., additional, Luxardi, Guillaume, additional, Maverakis, Emanual, additional, Abedi, Mehrdad, additional, Ranganathan, Raghuveer, additional, Zain, Jasmine, additional, Budde, Lihua E, additional, Mei, Matthew, additional, Rosenberg, Aaron S, additional, Hoeg, Rasmus T, additional, Costello, Caitlin, additional, Foss, Francine M., additional, William, Basem M., additional, Holland, H. Kent, additional, Villalona-Calero, Miguel, additional, Sharon, Elad, additional, and Tuscano, Joseph M, additional

Published
2022
Full Text
View/download PDF

38. Durable Leukemia and HIV Remission without Antiviral Therapy Following an Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) Using a Donor with CCR5-Δ32/Δ32 Homozygosity for an Acute Myeloid Leukemia (AML) Patient

Author

Aribi, Ahmed, primary, Budde, Lihua E, additional, Alvarnas, Joseph C., additional, Smith, Eileen P., additional, Salhotra, Amandeep, additional, Al Malki, Monzr M., additional, Yi-Ping, Wen, additional, Zaia, John, additional, Marcucci, Guido, additional, Dickter, Jana, additional, and Forman, Stephen J, additional

Published
2022
Full Text
View/download PDF

39. Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

Author

Aldoss, Ibrahim, primary, Khaled, Samer K., additional, Wang, Xiuli, additional, Palmer, Joycelynne, additional, Wang, Yan, additional, Wagner, Jamie R., additional, Clark, Mary C., additional, Simpson, Jennifer, additional, Paul, Jinny, additional, Vyas, Vibhuti, additional, Chien, Sheng-Hsuan, additional, Stein, Anthony, additional, Pullarkat, Vinod, additional, Salhotra, Amandeep, additional, Al Malki, Monzr M., additional, Aribi, Ahmed, additional, Sandhu, Karamjeet, additional, Thomas, Sandra H., additional, Budde, Lihua E., additional, Marcucci, Guido, additional, Brown, Christine E., additional, and Forman, Stephen J., additional

Published
2022
Full Text
View/download PDF

40. Abstract A22: Cost effectiveness of second line Axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma

Author

Kambhampati, Swetha, primary, Saumoy, Monica, additional, Schneider, Yecheskel, additional, Budde, Lihua E., additional, Danilov, Alexey, additional, Mei, Matthew, additional, Popplewell, Leslie, additional, Siddiqi, Tanya, additional, Zain, Jasmine, additional, Forman, Stephen, additional, Kwak, Larry, additional, Rosen, Steven, additional, Herrera, Alex, additional, and Thiruvengadam, Nikhil, additional

Published
2022
Full Text
View/download PDF

43. A phase 2, multicentre, open‐label trial ( ACE‐LY ‐003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma

Author

Strati, Paolo, primary, Coleman, Morton, additional, Champion, Rebecca, additional, Ma, Shuo, additional, Patti, Caterina, additional, Levy, Moshe Y., additional, Lossos, Izidore S., additional, Geethakumari, Praveen Ramakrishnan, additional, Lam, Selay, additional, Calvo, Roser, additional, Higgins, Kara, additional, and Budde, Lihua E., additional

Published
2022
Full Text
View/download PDF

44. Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma

Author

Zurko, Joanna, primary, Ramdial, Jeremy, additional, Shadman, Mazyar, additional, Ahmed, Sairah, additional, Szabo, Aniko, additional, Iovino, Lorenzo, additional, Tomas, Ana Alarcon, additional, Sauter, Craig, additional, Perales, Miguel-Angel, additional, Shah, Nirav. N., additional, Acharya, Utkarsh H., additional, Jacobson, Caron, additional, Soiffer, Robert J., additional, Wang, Trent, additional, Komanduri, Krishna V., additional, Jaglowski, Samantha, additional, Kittai, Adam S., additional, Denlinger, Nathan, additional, Iqbal, Madiha, additional, Kharfan-Dabaja, Mohamed A., additional, Ayala, Ernesto, additional, Chavez, Julio, additional, Jain, Michael, additional, Locke, Frederick L., additional, Samara, Yazeed, additional, Budde, Lihua E., additional, Mei, Matthew G., additional, Pia, Alexandra Della, additional, Feldman, Tatyana, additional, Ahmed, Nausheen, additional, Jacobs, Ryan, additional, Ghosh, Nilanjan, additional, Dholaria, Bhagirathbhai, additional, Oluwole, Olalekan O., additional, Hess, Brian, additional, Hassan, Ayesha, additional, Kenkre, Vaishalee P., additional, Reagan, Patrick, additional, Awan, Farrukh, additional, Nieto, Yago, additional, Hamadani, Mehdi, additional, and Herrera, Alex F., additional

Published
2022
Full Text
View/download PDF

46. Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology

Author

Thompson, John A., primary, Schneider, Bryan J., additional, Brahmer, Julie, additional, Achufusi, Amaka, additional, Armand, Philippe, additional, Berkenstock, Meghan K., additional, Bhatia, Shailender, additional, Budde, Lihua E., additional, Chokshi, Saurin, additional, Davies, Marianne, additional, Elshoury, Amro, additional, Gesthalter, Yaron, additional, Hegde, Aparna, additional, Jain, Michael, additional, Kaffenberger, Benjamin H., additional, Lechner, Melissa G., additional, Li, Tianhong, additional, Marr, Alissa, additional, McGettigan, Suzanne, additional, McPherson, Jordan, additional, Medina, Theresa, additional, Mohindra, Nisha A., additional, Olszanski, Anthony J., additional, Oluwole, Olalekan, additional, Patel, Sandip P., additional, Patil, Pradnya, additional, Reddy, Sunil, additional, Ryder, Mabel, additional, Santomasso, Bianca, additional, Shofer, Scott, additional, Sosman, Jeffrey A., additional, Wang, Yinghong, additional, Zaha, Vlad G., additional, Lyons, Megan, additional, Dwyer, Mary, additional, and Hang, Lisa, additional

Published
2022
Full Text
View/download PDF

47. Favorable Activity of CD19-Targeted Chimeric Antigen Receptor (CD19CAR) T Cell Therapy in Adults with Relapsed/ Refractory (R/R) ALL Including Extramedullary Disease (EMD) and Ph-like Genotype, Using Naive/Memory (Tn/ Mem) Derived T Cells

Author

Aldoss, Ibrahim, primary, Khaled, Samer K., additional, Blanchard, M. Suzette, additional, Wang, Xiuli, additional, Wagner, Jamie R., additional, Clark, Mary, additional, Simpson, Jennifer, additional, Paul, Jinny, additional, Stein, Anthony S., additional, Pullarkat, Vinod, additional, Salhotra, Amandeep, additional, Al Malki, Monzr M., additional, Thomas, Sandra, additional, Budde, Lihua E., additional, Marcucci, Guido, additional, Brown, Christine E., additional, and Forman, Stephen J., additional

Published
2022
Full Text
View/download PDF

48. Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study

Author

Budde, Lihua E., primary, Assouline, Sarit, additional, Sehn, Laurie H., additional, Schuster, Stephen J., additional, Yoon, Sung-Soo, additional, Yoon, Dok Hyun, additional, Matasar, Matthew J., additional, Bosch, Francesc, additional, Kim, Won Seog, additional, Nastoupil, Loretta J., additional, Flinn, Ian W., additional, Shadman, Mazyar, additional, Diefenbach, Catherine, additional, O'Hear, Carol, additional, Huang, Huang, additional, Kwan, Antonia, additional, Li, Chi-Chung, additional, Piccione, Emily C., additional, Wei, Michael C., additional, Yin, Shen, additional, and Bartlett, Nancy L., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results